Oklahoma PREVENT: PRogram to Enhance Vaccine Equity in Non-metropolitan and Tribal areas
Oklahoma PREVENT: PRogram to Enhance Vaccine Equity in Non-metropolitan and Tribal areas
批准号:
10400286
负责人:
JUDITH A JAMES
金额:
$30.58万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2023-06-30
关键词:
AddressAgingAmerican IndiansAmericasAreaArthritisAutoimmunityBiometryCaliberCardiovascular DiseasesCardiovascular systemCause of DeathCenter for Translational Science ActivitiesCessation of lifeChild HealthChildhoodChronic DiseaseClinicalClinical ResearchClinical SciencesClinical TrialsCollaborationsColon CarcinomaCommunicationCommunitiesCommunity NetworksCore FacilityCountyDataDevelopmentDevelopment PlansDiabetes MellitusDisciplineDiseaseEpidemiologyEyeFemaleFosteringFoundationsFundingGap JunctionsGoalsGrantHealthHealth PrioritiesHealth ProfessionalHealth systemHealthcareHeartHigh PrevalenceImmunizationIndividualIndustryInfrastructureInstitutionInvestmentsLeadershipLife ExpectancyLinkLongevityMalignant NeoplasmsMeasuresMedicalMentorsMinority GroupsMissionModelingObesityOklahomaOutcomePatientsPopulationPreventionPrimary Health CarePrivatizationProviderPublic HealthRegistriesResearchResearch InfrastructureResearch PersonnelResourcesRuralRural MinorityRural PopulationSamplingScientistSecureSmokingSourceStudentsTobacco Use CessationTobacco useTrainingTraining and InfrastructureTranslational ResearchTribesUnderrepresented MinorityUnderrepresented PopulationsUnderserved PopulationUnited States National Institutes of HealthVaccinesVisionVisitWorkWritingbiobankcancer health disparitycareercatalystclinical data warehouseclinical practicecommunity engaged researchdata resourcedata warehousedisabilitydissemination researchearly childhoodeducation resourceshealth disparityhealth equityimplementation researchimprovedimproved outcomeinterestmalignant breast neoplasmmedical schoolsmortalitynovelonline resourceopioid abuseopioid epidemicpatient registrypractice-based research networkprematureprogramsrecruitrepositorysuccesstooltraining opportunitytranslational research programtribal Nationtribal healthweb portal
中文摘要
点击翻译按钮获取中文摘要
英文摘要
An Oklahoma born in 2010 has the fifth lowest life-expectancy in the US and American Indians have the
shortest, 7.3 years less than the US average. Cancer, diabetes, cardiovascular disease, arthritis, and
autoimmunity are leading causes of disability and early mortality, serving as sources of major health disparities
in Oklahoma and other IDeA-states. Along with these diseases, tobacco use, opioid abuse, and child health
are also prominent health concerns. The primary mission of the Oklahoma Shared Clinical and Translational
Resources (OSCTR) is to improve health by catalyzing clinical and translational research (CTR) in these top
health priorities. To fulfill its mission, the OSCTR integrates health professionals, investigators, and scientific
resources at 29 public, private, and tribal partners/affiliate partners statewide. Oklahoma is an ideal setting for
these efforts due to these high rates of chronic diseases, and large rural and tribal populations where improved
health outcomes may serve as models across IDeA states. CTR on tribal health priorities and health equity is
fostered by strong relationships between OSCTR research institutions and tribal nations/health systems.
OSCTR houses the only CAP-certified biorepository affiliated with an IDeA-CTR, and cutting-edge resources
for data research and medical data warehouses. Oklahoma also has a growing cadre of junior investigators
who are launching independent CTR careers (most with OSCTR assistance), with institutional leaders who are
committed to CTR and improving Oklahomans health. Concurrent with these strengths, the OSCTR is
leveraging new partnerships to move toward prevention. Although many early successes are evident, CTR
sustainability in Oklahoma and its impact on public health are limited by ongoing needs for infrastructure
support and by a need for further development of the nascent clinical research infrastructure. Therefore, to
expand research into diseases with high prevalence in rural and tribal populations, the OSCTR is helping tribal
health systems build CTR infrastructure and fostering interactions through the Tribal Engagement Unit. To
launch independent CTR careers of junior investigators from multiple disciplines, the OSCTR provides training,
mentoring, pilot grants, and infrastructure. This includes patient registries, repositories, and data warehouses;
recruiting and regulatory support; biostatistical and epidemiologic expertise; and comprehensive online
resources linking investigators to relevant Core facilities at each OSCTR partner institution and Oklahoma
IDeA program. To engage health professionals, communities, and patients in high-priority CTR, the OSCTR
will develop an expanded online portal to educate patients and providers on CTR, and leverages a large
network of community-oriented health improvement organizations. Finally, to develop and share effective
infrastructure, the OSCTR collaborates with biomedical IDeA programs in Oklahoma and other states.
Together, these activities will help develop a critical mass of investigators to sustain Oklahoma’s CTR
infrastructure with a combination of federal funding, industry-sponsored clinical trials, and local support.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autoimmune Drivers and Protectors Team Science (ADAPTS)
-
批准号:10657232
-
项目类别:
-
资助金额:$132.33万
-
财政年份:2023
-
负责人:JUDITH A JAMES
-
依托单位:
Environmental Influences Driving Autoimmunity and Autoimmune Disease in Tribal Members
-
批准号:10438444
-
项目类别:
-
资助金额:$37.21万
-
财政年份:2022
-
负责人:JUDITH A JAMES
-
依托单位:
Environmental Influences Driving Autoimmunity and Autoimmune Disease in Tribal Members
-
批准号:10707068
-
项目类别:
-
资助金额:$37.54万
-
财政年份:2022
-
负责人:JUDITH A JAMES
-
依托单位:
Oklahoma Shared Clinical and Translational Resources
-
批准号:10293114
-
项目类别:
-
资助金额:$175.91万
-
财政年份:2021
-
负责人:JUDITH A JAMES
-
依托单位:
Oklahoma ACE: Molecular Deconstruction of Autoimmune Disease to Aid Clinical Trial Success
-
批准号:10608163
-
项目类别:
-
资助金额:$8.74万
-
财政年份:2019
-
负责人:JUDITH A JAMES
-
依托单位:
Oklahoma ACE: Molecular Deconstruction of Autoimmune Disease to Aid Clinical Trial Success
-
批准号:9901415
-
项目类别:
-
资助金额:$8.74万
-
财政年份:2019
-
负责人:JUDITH A JAMES
-
依托单位:
Oklahoma ACE: Molecular Deconstruction of Autoimmune Disease to Aid Clinical Trial Success
-
批准号:10396550
-
项目类别:
-
资助金额:$8.74万
-
财政年份:2019
-
负责人:JUDITH A JAMES
-
依托单位:
Oklahoma ACE: Molecular Deconstruction of Autoimmune Disease to Aid Clinical Trial Success
-
批准号:10158411
-
项目类别:
-
资助金额:$8.74万
-
财政年份:2019
-
负责人:JUDITH A JAMES
-
依托单位:
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)
-
批准号:10478206
-
项目类别:
-
资助金额:$87.4万
-
财政年份:2018
-
负责人:JUDITH A JAMES
-
依托单位:
Oklahoma Rheumatic Disease Research Cores Center
-
批准号:10704387
-
项目类别:
-
资助金额:$85.25万
-
财政年份:2018
-
负责人:JUDITH A JAMES
-
依托单位:
Molecular Phenotyping of Autoimmunity in Tribal Members: Aiding Precision Medicine and Tribal Student Training
-
批准号:10005381
-
项目类别:
-
资助金额:$39.1万
-
财政年份:2018
-
负责人:JUDITH A JAMES
-
依托单位:
Molecular Phenotyping of Autoimmunity in Tribal Members: Aiding Precision Medicine and Tribal Student Training
-
批准号:10246869
-
项目类别:
-
资助金额:$37.39万
-
财政年份:2018
-
负责人:JUDITH A JAMES
-
依托单位:
Administrative Core
-
批准号:10251963
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2018
-
负责人:JUDITH A JAMES
-
依托单位:
Administrative Core
-
批准号:10478207
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2018
-
负责人:JUDITH A JAMES
-
依托单位:
Administrative Core
-
批准号:10016169
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2018
-
负责人:JUDITH A JAMES
-
依托单位:
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)
-
批准号:10016168
-
项目类别:
-
资助金额:$87.4万
-
财政年份:2018
-
负责人:JUDITH A JAMES
-
依托单位:
Administrative Core
-
批准号:10704388
-
项目类别:
-
资助金额:$17.05万
-
财政年份:2018
-
负责人:JUDITH A JAMES
-
依托单位:
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)
-
批准号:10251962
-
项目类别:
-
资助金额:$87.4万
-
财政年份:2018
-
负责人:JUDITH A JAMES
-
依托单位:
Mechanisms of Lupus Disease Transition and Hydroxychloroquine Immune Modulation
-
批准号:9393206
-
项目类别:
-
资助金额:$46.07万
-
财政年份:2017
-
负责人:JUDITH A JAMES
-
依托单位:
Mechanisms of Lupus Disease Transition and Hydroxychloroquine Immune Modulation
-
批准号:9762586
-
项目类别:
-
资助金额:$46.07万
-
财政年份:2017
-
负责人:JUDITH A JAMES
-
依托单位:
海外基金